Hodgkin lymphoma

Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile

(2015) Johan H. Gibcus et al.   NEOPLASIA

Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma

(2012) E. Tiacci et al.   BLOOD

Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma

(2012) Claudia Otto et al.   BRITISH JOURNAL OF HAEMATOLOGY

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

(2012) Andreas Engert et al.   LANCET

Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma

(2011) S. Saarinen et al.   BLOOD

JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma

(2011) K. Van Roosbroeck et al.   BLOOD

MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma

(2011) Johan H. Gibcus et al.   JOURNAL OF PATHOLOGY

Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes

(2011) O Ammerpohl et al.   LEUKEMIA

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

(2011) Christian Steidl et al.   NATURE

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

(2011) Simonetta Viviani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumorigenic Potential of Mononucleated Small Cells of Hodgkin Lymphoma Cell Lines

(2010) Jun-ichiro Ikeda et al.   AMERICAN JOURNAL OF PATHOLOGY

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

(2010) M. R. Green et al.   BLOOD

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome

(2010) C. Steidl et al.   BLOOD

Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells

(2010) J. Stanelle et al.   BLOOD

Cooperative Epigenetic Modulation by Cancer Amplicon Genes

(2010) Lixin Rui et al.   CANCER CELL

The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin’s lymphoma

(2010) Makoto Nakashima et al.   CANCER SCIENCE

Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma

(2010) Jessica A. Shafer et al.   LEUKEMIA & LYMPHOMA

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

(2010) Victor Enciso-Mora et al.   NATURE GENETICS

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma

(2010) Björn Lamprecht et al.   NATURE MEDICINE

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

(2010) Andreas Engert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

(2010) Anas Younes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathogenesis of Classical and Lymphocyte-Predominant Hodgkin Lymphoma

(2009) Roland Schmitz et al.   Annual Review of Pathology-Mechanisms of Disease

Clonotypic B cells in classic Hodgkin lymphoma

(2009) R. Kuppers   BLOOD

Circulating clonotypic B cells in classic Hodgkin lymphoma

(2009) R. J. Jones et al.   BLOOD

Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma

(2009) A. Navarro et al.   BLOOD

Highly increased familial risks for specific lymphoma subtypes

(2009) Lynn R. Goldin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell linesversusCD77+B-cells reveals a distinct subset of differentially expressed miRNAs

(2009) Pieter Van Vlierberghe et al.   BRITISH JOURNAL OF HAEMATOLOGY

Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma

(2009) Boris Böll et al.   BRITISH JOURNAL OF HAEMATOLOGY

Mutations in the genes coding for the NF- B regulating factors I B  and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma

(2009) M. A. Schumacher et al.   HAEMATOLOGICA

Mutations ofNFKBIA, encoding IκBα, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases

(2009) Annette Lake et al.   INTERNATIONAL JOURNAL OF CANCER

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial

(2009) Massimo Federico et al.   JOURNAL OF CLINICAL ONCOLOGY

TNFAIP3(A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

(2009) Roland Schmitz et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Frequent inactivation of A20 in B-cell lymphomas

(2009) Motohiro Kato et al.   NATURE

Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells

(2009) S. J. Salipante et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis

(2008) F. A. Scheeren et al.   BLOOD

PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma

(2008) R. Yamamoto et al.   BLOOD

BCL2 and BCL3 are recurrent translocation partners of the IGH locus

(2008) Natalia Szymanowska et al.   CANCER GENETICS AND CYTOGENETICS

Side population cells in human cancers

(2008) Colleen Wu et al.   CANCER LETTERS

Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis

(2008) Verena Brune et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma

(2008) F Jundt et al.   LEUKEMIA

Involved-Node Radiotherapy in Early-Stage Hodgkin’s Lymphoma

(2008) Hans Theodor Eich et al.   STRAHLENTHERAPIE UND ONKOLOGIE